Natosha Dye v. HHS - Influenza, immune thrombocytopenic purpura (ITP) (2026)
Case summary [AI summaries can sometimes make mistakes]
On October 29, 2021, Natosha Dye filed a petition on behalf of K.A., a minor child, alleging that K.A. developed immune thrombocytopenic purpura after receiving an influenza vaccine on November 8, 2018. Respondent denied that the flu vaccine caused K.A.'s ITP and denied that any current condition was a sequela of a vaccine-related injury.
The public stipulation does not state K.A.'s exact age, platelet counts, bleeding symptoms, hospitalization, medication history, or recovery course. On February 25, 2026, Special Master Herbrina D.
S. Young adopted the parties' stipulation and awarded $80,000.00.
The award was payable through counsel's IOLTA account for prompt disbursement to Ms. Dye as guardian or conservator of K.A.'s estate.
K.A. was represented by Edward Kraus of Kraus Law Group, LLC.
Theory of causation
Influenza vaccine on November 8, 2018 causing ITP in minor child K.A.; exact age not stated in public stipulation. COMPENSATED by stipulation. Respondent denied vaccine causation and vaccine-related sequelae; public text lacks platelet/treatment chronology. Award $80,000 to counsel IOLTA for guardian/conservator disbursement. SM Herbrina D. S. Young; petition October 29, 2021; decision February 25, 2026. Attorney Edward Kraus, Kraus Law Group.
Source PDFs
USCOURTS-cofc-1_21-vv-02103